GOTHENBURG, Sweden -- The ability of monocytes to stimulate pro-inflammatory T cells is reduced in humans treated with glatiramer acetate (Copaxone).GOTHENBURG, Sweden -- The multiple sclerosis drug laquinimod, which crosses the blood-brain barrier, is safe for brain stem cells at concentrations relevant for treatment, according to a study presented here.GOTHENBURG, Sweden -- The oral immune modulator teriflunomide is effective and safe for treatment of MS patients with relapsing-remitting disease, a phase III study showed.GOTHENBURG, Sweden -- Glatiramer acetate acetate reduces MS fatigue after 1 year more than interferon beta-1b, according to a study.GOTHENBURG, Sweden -- The investigative monoclonal antibody laquinimod has multiple mechanisms of action in both the central nervous system and the periphery, investigators in two phase III studies reported here.GOTHENBURG, Sweden -- Low serum vitamin D at the time of a first demyelinating event increases the risk of subsequent multiple sclerosis (MS) in children, according to a new study.GOTHENBURG, Sweden -- Two annual treatments with alemtuzumab remain effective for at least five years in preventing disability progression in multiple sclerosis, although safety concerns remain.GOTHENBURG, Sweden -- Multiple sclerosis patients whose initial symptoms are in the optic pathway are not as likely to be started on treatment within the first two years as those in whom disease first shows up in the spinal cord, researchers said here.GOTHENBURG, Sweden -- New criteria for diagnosing multiple sclerosis with a single MRI have a sensitivity of up to 86% and a specificity of up to 75%, researchers said here.